edelfosine has been researched along with 9,10-dimethyl-1,2-benzanthracene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, MR; Schmähl, D | 2 |
2 other study(ies) available for edelfosine and 9,10-dimethyl-1,2-benzanthracene
Article | Year |
---|---|
Protection by the alkyllysophospholipid, 1-octadecyl-2-methoxy-rac-glycero-3-phosphocholine, but not by the retinoid etretinate against leukemia development in DMBA-treated Long-Evans rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Etretinate; Female; Leukemia, Experimental; Lysophosphatidylcholines; Lysophospholipids; Male; Mammary Neoplasms, Experimental; Phospholipid Ethers; Phospholipids; Rats | 1986 |
Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Leukemia, Experimental; Lysophospholipids; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Experimental; Organophosphates; Organophosphorus Compounds; Phospholipid Ethers; Rats; Rats, Inbred Strains | 1987 |